All In Biotech

Free tool

FAERS Monitor: Inflectra

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125544 or its brand name (Inflectra, Infliximab-Dyyb). Reports on generic versions are filed under their own applications.

Reports

29,668

Serious

24,848

84% of reports

Hospitalization

7,353

Death reported

722

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use15,555
  • condition aggravated10,827
  • intentional product use issue8,399
  • inappropriate schedule of product administration7,041
  • arthralgia5,039
  • drug ineffective3,658
  • fatigue3,494
  • weight increased3,200
  • weight decreased3,079
  • malaise2,963
  • headache2,464
  • nausea2,417
  • blood pressure increased2,396
  • covid-192,372
  • pain2,356

Reports by year received

View as table
YearReports
20157
2016168
20171,138
20182,497
20191,612
20202,604
20213,484
20224,878
20234,251
20244,072
20252,706
20262,251

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,024,491 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intentional product use issueSignal8,39975.173.6557,248
inappropriate schedule of product administrationSignal7,04128.828.2182,985
condition aggravatedSignal10,82726.125.7256,150
off label useSignal15,55512.812.7173,467
blood pressure increasedSignal2,39611.310.822,226
weight increasedSignal3,20010.39.926,645
covid-19Signal2,3729.79.318,409
arthralgiaSignal5,0398.78.534,525
weight decreasedSignal3,0797.97.618,577
malaiseSignal2,9634.84.79,082
fatigueSignal3,4943.23.15,433
headacheSignal2,4642.82.72,911
painSignal2,3562.72.62,640
nauseaSignal2,4172.22.11,575
drug ineffective3,6582.01.91,859

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.